While mammography, biopsies, and cancer diagnoses are up from 2020 lows, none have reached pre-COVID-19 volumes
Consider COVID Vax History When Assessing Adenopathy on Mammo
Axillary lymphadenopathy more likely within 14 days after vaccination; persistent axillary lymphadenopathy seen up to 43 weeks later
Breast Cancer Screening Down Among Low-Income Women During Pandemic
Eight percent drop in screenings at 32 community health centers means about 47,517 fewer mammograms, 242 missed breast cancer diagnoses
Screening Mammograms Plummeted During COVID-19 Pandemic
Drop in breast cancer screenings at one safety-net hospital raises concerns for worsening of preexisting health disparities
Routine Cancer Screenings Declined Significantly at Start of Pandemic
However, mammography and colonoscopy rates rebounded substantially by the end of July
Axillary Adenopathy Reported After Recent COVID-19 Vaccination
Management approach to these findings includes axillary ultrasound if clinical concern persists six weeks after final dose of vaccine